NCT07054346 2026-04-01
LUTACT
University of California, San Francisco
Phase 1 Recruiting
Clinical Trials
14 trialsNCT04167969 2026-03-27
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06435546 2026-03-27
AdOTAC
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT05435495 2026-03-18
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Recruiting
NCT06960798 2026-03-02
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
University of Oklahoma
Recruiting
NCT04662996 2026-02-12
MiR_CPMRC
University Hospital, Tours
Phase NA Completed
NCT02657863 2025-12-23
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT02869282 2025-09-17
CHEMOPROST
Institut Bergonié
Withdrawn
NCT05141383 2025-09-08
HOPE
Institut Curie
Phase NA Completed
NCT05011188 2025-08-27
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 1/2 Active not recruiting
NCT06942104 2025-07-18
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
Phase 1 Recruiting
NCT04581109 2025-07-10
EPIDROP
University Hospital, Montpellier
Phase NA Recruiting
NCT06904313 2025-06-04
Ultralow Dose PET Imaging for PSMA Expression
Nuclear Imaging Institute
Phase 2 Recruiting
NCT05819827 2025-04-27
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Terminated